SIHAO LIU
Inventor
Stats
- 0 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 5 US Applications Filed
- 3 Total Citation Count
- Dec 28, 2022 Most Recent Filing
- Jan 18, 2019 Earliest Filing
Work History
No Work History Available.Inventor Addresses
| Address | Duration |
|---|---|
| La Jolla, CA, US | May 23, 19 - May 23, 19 |
| San Diego, CA, US | Sep 12, 19 - Mar 13, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
| C07K: | PEPTIDES | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0082,781 | 2025 | METHODS OF LOWERING BLOOD GLUCOSE AND TREATING TYPE 2 DIABETES BY ACTIVATION OF PDE4D3 | 0 |
| 2023/0097,335 | 2023 | FIBROBLAST GROWTH FACTOR 1 (FGF1) MUTANT PROTEINS THAT SELECTIVELY ACTIVATE FGFR1B TO REDUCE BLOOD GLUCOSE | 0 |
| 11542309 | 2023 | Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose | 0 |
| 2021/0032,303 | 2021 | FIBROBLAST GROWTH FACTOR 1 (FGF1) MUTANT PROTEINS THAT SELECTIVELY ACTIVATE FGFR1B TO REDUCE BLOOD GLUCOSE | 0 |
| 2019/0276,510 | 2019 | USE OF FIBROBLAST GROWTH FACTOR 1 (FGF1)-VAGUS NERVE TARGETING CHIMERIC PROTEINS TO TREAT HYPERGLYCEMIA | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.